{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:46:44Z","timestamp":1793468804874,"version":"4.5.0"},"reference-count":159,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>B cells contribute to humoral immunity by producing antibodies, presenting antigens, and secreting cytokines. Traditionally, B cells have been viewed as predominantly pro-immunogenic effectors that promote adaptive immune responses. However, accumulating evidence has identified a distinct B cell subset with immunosuppressive properties, termed regulatory B cells (Bregs), which restrain pathogenic T-cell responses by secreting anti-inflammatory cytokines including interleukin-10 (IL-10), IL-35, and transforming growth factor \u03b2 (TGF-\u03b2), and by expressing immunoregulatory surface molecules such as T cell immunoglobulin and mucin domain 1 (Tim-1), programmed cell death protein 1 (PD-1), and Fas ligand (FasL). Through these mechanisms, Bregs contribute to immune homeostasis and the maintenance of immune tolerance. Moreover, published studies have linked Bregs to the progression of autoimmune diseases, and substantial experimental data support quantitative and functional abnormalities of Bregs across multiple autoimmune conditions. In this review, we summarize current knowledge regarding the developmental origin, phenotypic features, and biological functions of Bregs, with emphasis on their roles in autoimmune diseases. A deeper understanding of Bregs in autoimmunity may provide a promising foundation for future immunotherapeutic strategies.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1808399","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:25:34Z","timestamp":1775795134000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Regulatory B cells: heterogeneity, immunosuppressive networks, and contributions to autoimmune pathogenesis"],"prefix":"10.3389","volume":"17","author":[{"given":"Yikai","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University","place":["Haikou, Hainan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University","place":["Haikou, Hainan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Ji","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University","place":["Haikou, Hainan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University","place":["Haikou, Hainan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University","place":["Haikou, Hainan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zewei","family":"Mo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University","place":["Haikou, Hainan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Joint Surgery, Department of Orthopaedics, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University","place":["Haikou, Hainan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-016-0325-6","article-title":"Innate recognition of microbial-derived signals in immunity and inflammation","volume":"59","author":"Zhang","year":"2016","journal-title":"Sci China Life Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/science.abi5200","article-title":"The spectrum of inflammatory responses","volume":"374","author":"Medzhitov","year":"2021","journal-title":"Sci (New York NY)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J Intern Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104076","article-title":"Regulatory B cells in infection, inflammation, and autoimmunity","volume":"352","author":"Dasgupta","year":"2020","journal-title":"Cell Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"611795","DOI":"10.3389\/fimmu.2021.611795","article-title":"Immunosuppressive mechanisms of regulatory B cells","volume":"12","author":"Catal\u00e1n","year":"2021","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.592914","article-title":"Advances of regulatory B cells in autoimmune diseases","volume":"12","author":"Zhu","year":"2021","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/251550a0","article-title":"B-cell suppression of delayed hypersensitivity reactions","volume":"251","author":"Katz","year":"1974","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.113.6.1716","article-title":"Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity","volume":"113","author":"Neta","year":"1974","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.6.2271","article-title":"Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice","volume":"184","author":"Wolf","year":"1996","journal-title":"J Exp Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.10.1749","article-title":"Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice","volume":"186","author":"Mizoguchi","year":"1997","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/s1074-7613(02)00274-1","article-title":"Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation","volume":"16","author":"Mizoguchi","year":"2002","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/ni833","article-title":"B cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.04.005","article-title":"Regulatory B cells: origin, phenotype, and function","volume":"42","author":"Rosser","year":"2015","journal-title":"Immunity"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.582657","article-title":"Phenotypes, functions, and clinical relevance of regulatory B cells in cancer","volume":"11","author":"Shang","year":"2020","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1303214","article-title":"Human regulatory B cells combine phenotypic and genetic hallmarks with a distinct differentiation fate","volume":"193","author":"Lin","year":"2014","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201445082","article-title":"Transitional-2 B cells acquire regulatory function during tolerance induction and contribute to allograft survival","volume":"45","author":"Moreau","year":"2015","journal-title":"Eur J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.12.7868","article-title":"Novel suppressive function of transitional 2 B cells in experimental arthritis","volume":"178","author":"Evans","year":"2007","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14037","article-title":"MiR-15a\/16\u20131 deficiency induces IL-10-producing CD19(+) TIM-1(+) cells in tumor microenvironment","volume":"23","author":"Jia","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201546248","article-title":"MZ B cells migrate in a T-bet dependent manner and might contribute to the remission of collagen-induced arthritis by the secretion of IL-10","volume":"46","author":"Huber","year":"2016","journal-title":"Eur J Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s10020-018-0029-2","article-title":"B-1a cells protect mice from sepsis-induced acute lung injury","volume":"24","author":"Aziz","year":"2018","journal-title":"Mol Med (Cambridge Mass)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coph.2015.04.006","article-title":"Regulatory plasma cells","volume":"23","author":"Fillatreau","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41467-017-00838-4","article-title":"IL-12p35 induces expansion of IL-10 and IL-35-expressing regulatory B cells and ameliorates autoimmune disease","volume":"8","author":"Dambuza","year":"2017","journal-title":"Nat Commun"},{"key":"B23","doi-asserted-by":"publisher","first-page":"34594","DOI":"10.1038\/srep34594","article-title":"B cell-derived transforming growth factor-\u03b21 expression limits the induction phase of autoimmune neuroinflammation","volume":"6","author":"Bjarnad\u00f3ttir","year":"2016","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1172\/jci36030","article-title":"Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression","volume":"118","author":"Matsushita","year":"2008","journal-title":"J Clin Invest"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2010.10.022","article-title":"IL-10-producing regulatory B10 cells inhibit intestinal injury in a mouse model","volume":"178","author":"Yanaba","year":"2011","journal-title":"Am J Pathol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1401329","article-title":"B10 cells: a functionally defined regulatory B cell subset","volume":"194","author":"Tedder","year":"2015","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxv046","article-title":"Regulatory B10 cell development and function","volume":"27","author":"Lykken","year":"2015","journal-title":"Int Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.016","article-title":"Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation","volume":"41","author":"Matsumoto","year":"2014","journal-title":"Immunity"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-092419-031130","article-title":"Age-associated B cells","volume":"38","author":"Cancro","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"173ra23","DOI":"10.1126\/scitranslmed.3005407","article-title":"CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation","volume":"5","author":"Flores-Borja","year":"2013","journal-title":"Sci Transl Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/oxfimm\/iqae012","article-title":"The current understanding of the phenotypic and functional properties of human regulatory B cells (Bregs)","volume":"5","author":"Ahsan","year":"2024","journal-title":"Oxf Open Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cells13040357","article-title":"Regulatory B cells-immunopathological and prognostic potential in humans","volume":"13","author":"Veh","year":"2024","journal-title":"Cells"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110728","article-title":"Human IL-10-producing B cells have diverse states that are induced from multiple B cell subsets","volume":"39","author":"Glass","year":"2022","journal-title":"Cell Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01368","article-title":"APRIL induces a novel subset of IgA(+) regulatory B cells that suppress inflammation via expression of IL-10 and PD-L1","volume":"10","author":"Fehres","year":"2019","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/s1521-6616(03)00092-5","article-title":"Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM","volume":"108","author":"Shi","year":"2003","journal-title":"Clin Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s12016-025-09021-w","article-title":"Age-associated B cells in autoimmune diseases: pathogenesis and clinical implications","volume":"68","author":"Xie","year":"2025","journal-title":"Clin Rev Allergy Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/nri3795","article-title":"The generation of antibody-secreting plasma cells","volume":"15","author":"Nutt","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0057-8","article-title":"Natural regulatory plasma cells","volume":"18","author":"Flemming","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2018.09.012","article-title":"Natural regulatory plasma cells","volume":"55","author":"Fillatreau","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102880","article-title":"Marginal zone B cells regulate antigen-specific T cell responses during infection","volume":"188","author":"Bankoti","year":"2012","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1172\/jci46274","article-title":"Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice","volume":"121","author":"Ding","year":"2011","journal-title":"J Clin Invest"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001307","article-title":"Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis","volume":"185","author":"Matsushita","year":"2010","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nature12979","article-title":"IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases","volume":"507","author":"Shen","year":"2014","journal-title":"Nature"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201445211","article-title":"Ligation of TLR7 on CD19(+) CD1d(hi) B cells suppresses allergic lung inflammation via regulatory T cells","volume":"45","author":"Khan","year":"2015","journal-title":"Eur J Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300649","article-title":"Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-\u03b3+CD4+ T cell numbers during colitis development in mice","volume":"191","author":"Maseda","year":"2013","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.07.843","article-title":"The unknown aspect of BAFF: inducing IL-35 production by a CD5(+)CD1d(hi)Fc\u03b3RIIb(hi) regulatory B-cell subset in lupus","volume":"137","author":"Zhang","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.2.1081","article-title":"Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice","volume":"167","author":"Tian","year":"2001","journal-title":"J Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1038\/ncomms6997","article-title":"PD-L1hi B cells are critical regulators of humoral immunity","volume":"6","author":"Khan","year":"2015","journal-title":"Nat Commun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400336","article-title":"A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production","volume":"193","author":"Kaku","year":"2014","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/all.12697","article-title":"A regulatory CD9(+) B-cell subset inhibits HDM-induced allergic airway inflammation","volume":"70","author":"Braza","year":"2015","journal-title":"Allergy"},{"key":"B54","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1053\/j.gastro.2017.09.045","article-title":"MicroRNAs 15A and 16\u20131 activate signaling pathways that mediate chemotaxis of immune regulatory B cells to colorectal tumors","volume":"154","author":"Liu","year":"2018","journal-title":"Gastroenterology"},{"key":"B55","doi-asserted-by":"publisher","first-page":"14386","DOI":"10.1038\/s41598-020-71362-7","article-title":"Accumulation of synovial fluid CD19(+)CD24(hi)CD27(+) B cells was associated with bone destruction in rheumatoid arthritis","volume":"10","author":"Guo","year":"2020","journal-title":"Sci Rep"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-09-599159","article-title":"CD24(hi)CD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease","volume":"125","author":"de Masson","year":"2015","journal-title":"Blood"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.01.014","article-title":"IgG4 production is confined to human IL-10-producing regulatory B cells that suppress antigen-specific immune responses","volume":"131","author":"van de Veen","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu257","article-title":"Interleukin 10 (IL-10)-producing CD1dhi regulatory B cells from Schistosoma haematobium-infected individuals induce IL-10-positive T cells and suppress effector T-cell cytokines","volume":"210","author":"van der Vlugt","year":"2014","journal-title":"J Infect Dis"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8872-0","article-title":"CD19+ Tim-1+ B cells are decreased and negatively correlated with disease severity in Myasthenia Gravis patients","volume":"64","author":"Zhang","year":"2016","journal-title":"Immunol Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2017.11.010","article-title":"Killer (FASL regulatory) B cells are present during latent TB and are induced by BCG stimulation in participants with and without latent tuberculosis","volume":"108","author":"van Rensburg","year":"2018","journal-title":"Tuberculosis (Edinb)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02241","article-title":"PD-L1(+) regulatory B cells are significantly decreased in rheumatoid arthritis patients and increase after successful treatment","volume":"9","author":"Zacca","year":"2018","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402568","article-title":"CD4+ T cell-derived IL-21 and deprivation of CD40 signaling favor the in vivo development of granzyme B-expressing regulatory B cells in HIV patients","volume":"194","author":"Kaltenmeier","year":"2015","journal-title":"J Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200940113","article-title":"CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B","volume":"40","author":"Hagn","year":"2010","journal-title":"Eur J Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2013-02-482406","article-title":"Adenosine production by human B cells and B cell-mediated suppression of activated T cells","volume":"122","author":"Saze","year":"2013","journal-title":"Blood"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03034","article-title":"CD9(+) regulatory B cells induce T cell apoptosis via IL-10 and are reduced in severe asthmatic patients","volume":"9","author":"Brosseau","year":"2018","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.24","article-title":"Altered B cell signalling in autoimmunity","volume":"17","author":"Rawlings","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/all.14763","article-title":"Regulatory B cells, A to Z","volume":"76","author":"Jansen","year":"2021","journal-title":"Allergy"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190418","article-title":"Biology and therapeutic potential of interleukin-10","volume":"217","author":"Saraiva","year":"2020","journal-title":"J Exp Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838331","article-title":"Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells","volume":"38","author":"Gu","year":"2008","journal-title":"Eur J Immunol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1639","article-title":"Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigens","volume":"64","author":"Kleffel","year":"2015","journal-title":"Diabetes"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-84828-0_551","article-title":"Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL\/lpr mice","volume":"182","author":"Blair","year":"2009","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.588500","article-title":"Granulocytic myeloid-derived suppressor cell exosomal prostaglandin E2 ameliorates collagen-induced arthritis by enhancing IL-10(+) B cells","volume":"11","author":"Wu","year":"2020","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-571125","article-title":"Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD","volume":"124","author":"Khoder","year":"2014","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.1994-16.2016","article-title":"Regulatory B cells induce formation of IL-10-expressing T cells in mice with autoimmune neuroinflammation","volume":"36","author":"Pennati","year":"2016","journal-title":"J Neurosci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00961","article-title":"IL-10 producing B cells ability to induce regulatory T cells is maintained in rheumatoid arthritis","volume":"9","author":"Mielle","year":"2018","journal-title":"Front Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2019.101324","article-title":"Epigenetic and transcriptional mechanisms for the regulation of IL-10","volume":"44","author":"Zhang","year":"2019","journal-title":"Semin Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1952","article-title":"IL-35-mediated induction of a potent regulatory T cell population","volume":"11","author":"Collison","year":"2010","journal-title":"Nat Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.7150\/thno.90608","article-title":"Adaptive plasticity of natural interleukin-35-induced regulatory T cells (Tr35) that are required for T-cell immune regulation","volume":"14","author":"Wei","year":"2024","journal-title":"Theranostics"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12639","article-title":"Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)\/lpr mice","volume":"181","author":"Cai","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2015.07.013","article-title":"Interleukin 35: Critical regulator of immunity and lymphocyte-mediated diseases","volume":"26","author":"Egwuagu","year":"2015","journal-title":"Cytokine Growth Factor Rev"},{"key":"B81","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev.immunol.24.021605.090737","article-title":"Transforming growth factor-beta regulation of immune responses","volume":"24","author":"Li","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/359693a0","article-title":"Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease","volume":"359","author":"Shull","year":"1992","journal-title":"Nature"},{"key":"B83","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nri704","article-title":"Transforming growth factor-beta in T-cell biology","volume":"2","author":"Gorelik","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030152","article-title":"Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3","volume":"198","author":"Chen","year":"2003","journal-title":"J Exp Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.137.12.3855","article-title":"Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes","volume":"137","author":"Kehrl","year":"1986","journal-title":"J Immunol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.11.018","article-title":"Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells","volume":"11","author":"Kessel","year":"2012","journal-title":"Autoimmun Rev"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-01036-7","article-title":"Intricacies of TGF-\u03b2 signaling in Treg and Th17 cell biology","volume":"20","author":"Wang","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.5ru0518-199r","article-title":"Regulatory B cells and advances in transplantation","volume":"105","author":"Li","year":"2019","journal-title":"J Leukocyte Biol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/nri2366","article-title":"New roles for TIM family members in immune regulation","volume":"8","author":"Kuchroo","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-058800","article-title":"TIM-1 and TIM-3 enhancement of Th2 cytokine production by mast cells","volume":"110","author":"Nakae","year":"2007","journal-title":"Blood"},{"key":"B91","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12020-019-02173-8","article-title":"The expression of Tim-1 and Tim-4 molecules in regulatory T cells in type 1 diabetes","volume":"68","author":"Guo","year":"2020","journal-title":"Endocrine"},{"key":"B92","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/j.1365-2567.2010.03276.x","article-title":"Tim-1 is induced on germinal centre B cells through B-cell receptor signalling but is not essential for the germinal centre response","volume":"131","author":"Wong","year":"2010","journal-title":"Immunology"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1172\/jci32562","article-title":"Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice","volume":"118","author":"Degauque","year":"2008","journal-title":"J Clin Invest"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1120914109","article-title":"Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice","volume":"109","author":"Xiao","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1213-9","article-title":"TIM-1 defines a human regulatory B cell population that is altered in frequency and function in systemic sclerosis patients","volume":"19","author":"Aravena","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.748787","article-title":"Novel roles of the Tim family in immune regulation and autoimmune diseases","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.11.011","article-title":"TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells","volume":"27","author":"Kobayashi","year":"2007","journal-title":"Immunity"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065x.2010.00923.x","article-title":"The PD-1 pathway in tolerance and autoimmunity","volume":"236","author":"Francisco","year":"2010","journal-title":"Immunol Rev"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2021.101480","article-title":"Emerging concepts in PD-1 checkpoint biology","volume":"52","author":"Pauken","year":"2021","journal-title":"Semin Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20090847","article-title":"PD-L1 regulates the development, maintenance, and function of induced regulatory T cells","volume":"206","author":"Francisco","year":"2009","journal-title":"J Exp Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2017.1413520","article-title":"A novel MDSC-induced PD-1(-)PD-L1(+) B-cell subset in breast tumor microenvironment possesses immuno-suppressive properties","volume":"7","author":"Shen","year":"2018","journal-title":"Oncoimmunology"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2019.02.009","article-title":"PD-1-expressing B cells suppress CD4(+) and CD8(+) T cells via PD-1\/PD-L1-dependent pathway","volume":"109","author":"Wang","year":"2019","journal-title":"Mol Immunol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01489-2","article-title":"Combination strategies with PD-1\/PD-L1 blockade: current advances and future directions","volume":"21","author":"Yi","year":"2022","journal-title":"Mol Cancer"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202106265","article-title":"Mesenchymal stem cell-derived extracellular vesicles with high PD-L1 expression for autoimmune diseases treatment","volume":"34","author":"Xu","year":"2022","journal-title":"Adv Mater"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1038\/srep35651","article-title":"PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer","volume":"6","author":"Guan","year":"2016","journal-title":"Sci Rep"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00403","article-title":"Dual role of Fas\/FasL-mediated signal in peripheral immune tolerance","volume":"8","author":"Yamada","year":"2017","journal-title":"Front Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1615\/critrevimmunol.2014009988","article-title":"Mechanism of activation-induced cell death of T cells and regulation of FasL expression","volume":"34","author":"Arakaki","year":"2014","journal-title":"Crit Rev Immunol"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2017.04.016","article-title":"TLR4 supports the expansion of FasL(+)CD5(+)CD1d(hi) regulatory B cells, which decreases in contact hypersensitivity","volume":"87","author":"Wang","year":"2017","journal-title":"Mol Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"R128","DOI":"10.1186\/ar2795","article-title":"Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis","volume":"11","author":"Lundy","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B111","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/eji.201444625","article-title":"Antitumor effector B cells directly kill tumor cells via the Fas\/FasL pathway and are regulated by IL-10","volume":"45","author":"Tao","year":"2015","journal-title":"Eur J Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774","article-title":"The role of Fas\/FasL interactions in the regulation of B cell function","author":"Jacobson","year":"1996","journal-title":"Behring Inst Mitt"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1172\/jci85113","article-title":"Human regulatory B cells in health and disease: therapeutic potential","volume":"127","author":"Mauri","year":"2017","journal-title":"J Clin Invest"},{"key":"B114","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/978-981-15-3532-1_2","article-title":"B cell receptor signaling","volume":"1254","author":"Tanaka","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.08.041","article-title":"PI3 kinase signals BCR-dependent mature B cell survival","volume":"139","author":"Srinivasan","year":"2009","journal-title":"Cell"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.146.5.1685","article-title":"Inducible nuclear expression of NF-kappa B in primary B cells stimulated through the surface Ig receptor","volume":"146","author":"Liu","year":"1991","journal-title":"J Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/s0092-8674(00)80373-6","article-title":"In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death","volume":"90","author":"Lam","year":"1997","journal-title":"Cell"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102500","article-title":"Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo","volume":"188","author":"Maseda","year":"2012","journal-title":"J Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.11.7225","article-title":"Intravenous transfusion of BCR-activated B cells protects NOD mice from type 1 diabetes in an IL-10-dependent manner","volume":"179","author":"Hussain","year":"2007","journal-title":"J Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0900270","article-title":"The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals","volume":"182","author":"Yanaba","year":"2009","journal-title":"J Immunol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1242\/dev.156018","article-title":"Toll and Toll-like receptor signalling in development","volume":"145","author":"Anthoney","year":"2018","journal-title":"Dev (Cambridge England)"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774","article-title":"Toll-like receptor signaling and its role in cell-mediated immunity","volume":"13","author":"Duan","year":"2022","journal-title":"Front Immunol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2011.01.016","article-title":"Toll-like receptor driven B cell activation in the induction of systemic autoimmunity","volume":"23","author":"Green","year":"2011","journal-title":"Semin Immunol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s10875-005-0355-6","article-title":"TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production","volume":"25","author":"Lenert","year":"2005","journal-title":"J ClinImmunol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/nri3190","article-title":"Integration of B cell responses through Toll-like receptors and antigen receptors","volume":"12","author":"Rawlings","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00314","article-title":"Inflammatory role of TLR-MyD88 signaling in multiple sclerosis","volume":"12","author":"Zheng","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.7.4763","article-title":"TLR-activated B cells suppress T cell-mediated autoimmunity","volume":"180","author":"Lampropoulou","year":"2008","journal-title":"J Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201040673","article-title":"IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro","volume":"40","author":"Bouaziz","year":"2010","journal-title":"Eur J Immunol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1109173109","article-title":"A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells","volume":"109","author":"Miles","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-1237-8_13","article-title":"Use of Toll-like receptor (TLR) ligation to characterize human regulatory B-cells subsets","volume":"2270","author":"Chay\u00e9","year":"2021","journal-title":"Methods Mol Biol (Clifton NJ)"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199102000-00004","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N Engl J Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-021-00556-y","article-title":"Apparent changes in the epidemiology and severity of multiple sclerosis","volume":"17","author":"Koch-Henriksen","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-1161-5_17","article-title":"Regulatory B cells in experimental autoimmune encephalomyelitis (EAE)","volume":"1190","author":"Ray","year":"2014","journal-title":"Methods Mol Biol (Clifton NJ)"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.050923","article-title":"Inhibitory role of CD19 in the progression of experimental autoimmune encephalomyelitis by regulating cytokine response","volume":"168","author":"Matsushita","year":"2006","journal-title":"Am J Pathol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2003","article-title":"A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties","volume":"15","author":"Rafei","year":"2009","journal-title":"Nat Med"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103354","article-title":"A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand","volume":"188","author":"Ray","year":"2012","journal-title":"J Immunol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clim.2017.04.014","article-title":"Effector and regulatory B cells in multiple sclerosis","volume":"184","author":"Staun-Ram","year":"2017","journal-title":"Clin Immunol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214502","article-title":"Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity","volume":"78","author":"Jesus","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.5014\/ajot.2017.71s1-po4123","article-title":"Systemic lupus erythematosus: a review","volume":"331","author":"Siegel","year":"2024","journal-title":"Jama"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902385","article-title":"Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity","volume":"184","author":"Watanabe","year":"2010","journal-title":"J Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-022-00279-8","article-title":"CD19+CD24highCD27+ B cell and interleukin 35 as potential biomarkers of disease activity in systemic lupus erythematosus patients","volume":"62","author":"Xiong","year":"2022","journal-title":"Adv Rheumatol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12865-020-00388-3","article-title":"Assessing the expression of immunosuppressive cytokines in the newly diagnosed systemic lupus erythematosus patients: a focus on B cells","volume":"21","author":"Abbasifard","year":"2020","journal-title":"BMC Immunol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2021.09.012","article-title":"Impaired granzyme B-producing regulatory B cells in systemic lupus erythematosus","volume":"140","author":"Bai","year":"2021","journal-title":"Mol Immunol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088441","article-title":"T follicular helper cells and regulatory B cells dynamics in systemic lupus erythematosus","volume":"9","author":"Yang","year":"2014","journal-title":"PloS One"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1230264","article-title":"Pathogenesis and novel therapeutics of regulatory T cell subsets and interleukin-2 therapy in systemic lupus erythematosus","volume":"14","author":"Tsai","year":"2023","journal-title":"Front Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202413144","article-title":"Hspa13 deficiency impaired marginal zone B cells regulatory function and contributed to lupus pathogenesis","volume":"12","author":"Xing","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-52974-1_3","article-title":"Role of CD19(+) CD5(+) CD1d(+) Bregs in maintaining the Th17\/Treg balance in mice with systemic lupus erythematosus complicated with atherosclerosis","volume":"26","author":"Zhu","year":"2023","journal-title":"Int J Rheum Dis"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13663","article-title":"Altered peripheral B lymphocyte homeostasis and functions mediated by IL-27 via activating the mammalian target of rapamycin signaling pathway in patients with rheumatoid arthritis","volume":"206","author":"Tang","year":"2021","journal-title":"Clin Exp Immunol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102423","article-title":"Endoplasmic reticulum-associated degradation and beyond: the multitasking roles for HRD1 in immune regulation and autoimmunity","volume":"109","author":"Xu","year":"2020","journal-title":"J Autoimmun"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113518","article-title":"Neutrophil extracellular traps in rheumatoid arthritis: activating fibroblast-like synoviocytes via ATP citrate lyase","volume":"143","author":"Li","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13020-025-01209-8","article-title":"Potential mechanisms of acupuncture treatment for rheumatoid arthritis: a study based on network topology and machine learning","volume":"20","author":"Li","year":"2025","journal-title":"Chin Med"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.2337\/db25-0241","article-title":"B lymphocytes impede Tregs to erode islet tolerance in type 1 diabetes","volume":"75","author":"Wilson","year":"2025","journal-title":"Diabetes"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.773896","article-title":"Altered Tim-1 and IL-10 expression in regulatory B cell subsets in type 1 diabetes","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1450366","article-title":"The role of B cells in the pathogenesis of type 1 diabetes","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1101\/2024.07.03.601778","article-title":"Altered B cell metabolic pathways characterize type 1 diabetes progression","volume":"215","author":"Conway","year":"2025","journal-title":"J Immunol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1565158","article-title":"The immune tolerance role of Bregs in inhibiting human inflammatory diseases, with a focus on diabetes mellitus","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3724\/abbs.2025171","article-title":"Single-cell transcriptomics reveals apolipoprotein A4-mediated metabolic-immune reprogramming in lymphocytes during early obesity-related chronic kidney disease","volume":"57","author":"Wei","year":"2025","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-024-04040-7","article-title":"The characteristic activity of regulatory B cells during the occurrence and development of insulin resistance","volume":"87","author":"Wei","year":"2025","journal-title":"Endocrine"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1681082","article-title":"The half-century odyssey of regulatory B cells: from Breg discovery to emerging frontiers","volume":"16","author":"Zheremyan","year":"2025","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1808399\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:25:37Z","timestamp":1775795137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1808399\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":159,"alternative-id":["10.3389\/fimmu.2026.1808399"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1808399","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"article-number":"1808399"}}